Our in silico analysis showed that, together with miR-21-5p, miR-26a-5p and miR-222-3p targeted the PTEN gene, suggesting that the PI3K-AKT insulin signaling pathway should be further explored as a potential therapeutic target for insulin resistance in PCOS. This evidence concerns the gene PTEN and Insulin resistance.